Manning & Napier Group's ELV Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 367,297 shares of Elevance Health, Inc. (ELV) worth $142.52 M, representing 1.83% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Manning & Napier Group has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 344,237 shares. Largest reduction occurred in Q2 2026, reducing 107,904 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -107,904 | Reduce 22.71% | 367,297 | $388.03 |
| Q1 2026 | +106,775 | Add 28.98% | 475,201 | $292.75 |
| Q4 2025 | +344,237 | Add 1423.11% | 368,426 | $350.55 |
| Q3 2025 | -14,025 | Reduce 36.70% | 24,189 | $323.12 |
| Q2 2025 | +20,455 | Add 115.18% | 38,214 | $388.96 |
| Q1 2025 | +8,613 | Add 94.17% | 17,759 | $434.96 |
| Q4 2024 | +9,146 | New Buy | 9,146 | $368.90 |
| Q2 2020 | -911 | Sold Out | 911 | $226.13 |
| Q1 2020 | -15 | Reduce 1.62% | 911 | $226.13 |
| Q4 2019 | +926 | New Buy | 926 | $301.30 |
Manning & Napier Group's Elevance Health Investment FAQs
Manning & Napier Group first purchased Elevance Health, Inc. (ELV) in Q4 2019, acquiring 926 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Elevance Health, Inc. (ELV) for 27 quarters since Q4 2019.
Manning & Napier Group's largest addition to Elevance Health, Inc. (ELV) was in Q4 2025, adding 368,426 shares worth $129.15 M.
According to the latest 13F filing for Q2 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 367,297 shares of Elevance Health, Inc. (ELV), valued at approximately $142.52 M.
As of the Q2 2026 filing, Elevance Health, Inc. (ELV) represents approximately 1.83% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Elevance Health, Inc. (ELV) was 475,201 shares, as reported at the end of Q1 2026.